Standardisation of spirometry

M. R. Miller,J. Hankinson,V. Brusasco,F. Burgos,R. Casaburi,A. Coates,R. Crapo,P. Enright,C. P. M. van der Grinten,P. Gustafsson,R. Jensen,D. C. Johnson,N. MacIntyre,R. McKay,D. Navajas,O. F. Pedersen,R. Pellegrino,G. Viegi,J. Wanger

DOI: https://doi.org/10.1183/09031936.05.00034805

IF: 24.3

2005-08-01

European Respiratory Journal

Abstract:⇓

respiratory system

What problem does this paper attempt to address?

Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement

Brian L. Graham,Irene Steenbruggen,Martin R. Miller,Igor Z. Barjaktarevic,Brendan G. Cooper,Graham L. Hall,Teal S. Hallstrand,David A. Kaminsky,Kevin McCarthy,Meredith C. McCormack,Cristine E. Oropez,Margaret Rosenfeld,Sanja Stanojevic,Maureen P. Swanney,Bruce R. Thompson

DOI: https://doi.org/10.1164/rccm.201908-1590ST

IF: 24.7

2019-11-26

American Journal of Respiratory and Critical Care Medicine

Abstract:Background: Spirometry is the most common pulmonary function test. It is widely used in the assessment of lung function to provide objective information used in the diagnosis of lung diseases and m...

respiratory system,critical care medicine
ERS/ATS technical standard on interpretive strategies for routine lung function tests

Sanja Stanojevic,David A. Kaminsky,Martin R. Miller,Bruce Thompson,Andrea Aliverti,Igor Barjaktarevic,Brendan G. Cooper,Bruce Culver,Eric Derom,Graham L. Hall,Teal S. Hallstrand,Joerg D. Leuppi,Neil MacIntyre,Meredith McCormack,Margaret Rosenfeld,Erik R. Swenson,Martin Miller

DOI: https://doi.org/10.1183/13993003.01499-2021

IF: 24.3

2021-12-23

European Respiratory Journal

Abstract:Background Appropriate interpretation of pulmonary function tests (PFTs) involves the classification of observed values as within/outside the normal range based on a reference population of healthy individuals, integrating knowledge of physiologic determinants of test results into functional classifications, and integrating patterns with other clinical data to estimate prognosis. In 2005, the American Thoracic Society and the European Respiratory Society jointly adopted technical standards for the interpretation of PFTs. We aimed to update the 2005 recommendations and incorporate evidence from recent literature to establish new standard for PFT interpretation. Methods This technical standards document was developed by an international joint task force, appointed by the European Respiratory Society and the American Thoracic Society with multidisciplinary expertise in conducting and interpreting pulmonary function tests, and developing international standards. A comprehensive literature review was conducted, and published evidence was reviewed. Results Recommendations for the choice of reference equations and limits of normal of the healthy population to identify individuals with unusually low or high results, respectively are discussed. Interpretation strategies for bronchodilator responsiveness testing, limits of natural changes over time and severity are also updated. Interpretation of measurements made by spirometry, lung volumes and gas transfer are described as they relate to underlying pathophysiology with updated classification protocols of common impairments. Conclusions PFTs interpretation must be complemented with clinical expertise and consider the inherent biological variability of the test and the uncertainty of the test result to ensure appropriate interpretation of an individual's lung function measurements.

respiratory system
Clinlcal study of Medikro SplroStar USB portable splrometry application

Zhen-hua ZHU,Li LI,Xiao-cong FANG, BAI

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2011.018.003

2011-01-01

Abstract:Objective To compare the consistency of pulmonary function test (PFT) determinations by means of Medikro SpiroStar USB portable spirometry and traditional Jaeger MasterScreen IOS spirometer in people of different pulmonary function status. Methods One hundred people underwent PFT by means of both Medikro SpiroStar USB portable spirometry and traditional Jaeger MasterScreen IOS spirometer, pulmonary function of whom were either normal, or obstructive or restrictive or mixed ventilation dysfunction. Several key parameters (VC, FVC, FEV1, FEV1 ％ pred,FEV1/FVC) were analyzed and compared by means of in-group correlation coefficient (ICC) and Bland-Altman method. Results Compared with Jaeger spirometer, SpiroStar spirometry had no significant biases of the key pulmonary function parameters. The ICC values were as follows respectively: 0.968,0.970,0.977,0.967 and 0.938. The differences of two tests of the parameters were mostly (over 94％)in the range of 95％ consistency interval. Conclusions Compared with traditional Jaeger spirometer,SpiroStar spirometry has no significant biases of the key pulmonary function parameters such as VC,FVC, FEV1, FEV1 ％pred and FEV1/FVC. Thus, when the standardized PFT in pulmonary function lab is not available, SpiroStar USB portable spirometry will be a desirable alternative.
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations

Philip H. Quanjer,Sanja Stanojevic,Tim J. Cole,Xaver Baur,Graham L. Hall,Bruce H. Culver,Paul L. Enright,John L. Hankinson,Mary S.M. Ip,Jinping Zheng,Janet Stocks,J. Stocks,X. Baur,G.L. Hall,B. Culver,P.H. Quanjer,S. Stanojevic,T.J. Cole,J.L. Hankinson,P.L. Enright,J. Zheng,M.S.M. Ip,C. Schindler,

DOI: https://doi.org/10.1183/09031936.00080312

IF: 24.3

2012-06-27

European Respiratory Journal

Abstract:The aim of the Task Force was to derive continuous prediction equations and their lower limits of normal for spirometric indices, which are applicable globally. Over 160,000 data points from 72 centres in 33 countries were shared with the European Respiratory Society Global Lung Function Initiative. Eliminating data that could not be used (mostly missing ethnic group, some outliers) left 97,759 records of healthy nonsmokers (55.3% females) aged 2.5-95 yrs. Lung function data were collated and prediction equations derived using the LMS method, which allows simultaneous modelling of the mean (mu), the coefficient of variation (sigma) and skewness (lambda) of a distribution family. After discarding 23,572 records, mostly because they could not be combined with other ethnic or geographic groups, reference equations were derived for healthy individuals aged 3-95 yrs for Caucasians (n=57,395), African-Americans (n=3,545), and North (n=4,992) and South East Asians (n=8,255). Forced expiratory value in 1 s (FEV(1)) and forced vital capacity (FVC) between ethnic groups differed proportionally from that in Caucasians, such that FEV(1)/FVC remained virtually independent of ethnic group. For individuals not represented by these four groups, or of mixed ethnic origins, a composite equation taken as the average of the above equations is provided to facilitate interpretation until a more appropriate solution is developed. Spirometric prediction equations for the 3-95-age range are now available that include appropriate age-dependent lower limits of normal. They can be applied globally to different ethnic groups. Additional data from the Indian subcontinent and Arabic, Polynesian and Latin American countries, as well as Africa will further improve these equations in the future.

respiratory system
Standard spirometry to assess emphysema in patients with chronic obstructive pulmonary disease: the Emphysema Severity Index (ESI)

Roberto W. Dal Negro,Matteo Paoletti,Massimo Pistolesi,Matteo Poletti

DOI: https://doi.org/10.4081/mrm.2021.805

2021-12-06

Multidisciplinary Respiratory Medicine

Abstract:Background: Chronic obstructive pulmonary disease (COPD) is a generic term identifying a condition characterized by variable changes in peripheral airways and lung parenchyma. Standard spirometry cannot discriminate the relative role of conductive airways inflammatory changes from destructive parenchymal emphysema changes. The aim of this study was to quantify the emphysema component in COPD by a simple parameter (the Emphysema Severity Index - ESI), previously proved to reflect CT-assessed emphysema.Methods: ESI was obtained by fitting the descending limb of MEFV curves by a fully automated procedure providing a 0 to 10 score of emphysema severity. ESI was computed in COPD patients enrolled in the CLIMA Study.Results: the vast majority of ESI values ranged from 0 to 4, compatible with no-to-mild/moderate emphysema component. A limited proportion of patients showed ESI values >4, compatible with severe-to-very severe emphysema. ESI values were greatly dispersed within each GOLD class indicating that GOLD classification cannot discriminate emphysema and conductive airways changes in patients with similar airflow limitation. ESI and diffusing capacity (DLCO) were significantly correlated (p<0.001). However, the great dispersion in their correlation suggests that ESI and DLCO reflect partially different anatomo-functional determinants in COPD.Conclusions: airflow limitation has heterogenous determinants in COPD. Inflammatory and destructive changes may combine in CT densitometric alterations that cannot be detected by standard spirometry. ESI computation from spirometric data helps to define the prevailing pathogenetic mechanism underlying the measured airflow limitation. ESI could be a reliable advancement to select large samples of patients in clinical or epidemiological trials, and to compare different pharmacological treatments.
Performance Evaluation of Contemporary Spirometers

Steven B. Nelson,Reed M. Gardner,Robert O. Crapo,Robert L. Jensen

DOI: https://doi.org/10.1378/chest.97.2.288

IF: 9.6

1990-02-01

Chest

Abstract:A comprehensive evaluation of 62 spirometers from 37 different sources was performed using a two-part protocol: calibrated syringe, and dynamic waveform testing. All testing was done with ambient air. Calibrated syringe testing examined the ability of the spirometers to accurately measure the output of a 3 L calibrating syringe under varying conditions. The accuracy, FVC volume linearity, and stability of each spirometer was determined from these data. All but five of 42 spirometers accurately measured a 3 L calibrating syringe to within +/- 3 percent. Dynamic waveform testing consisted of introducing 24 standard waveforms into the spirometer from a computer-controlled air pump. The values of FVC, FEV1, and FEF25-75% were compared to the actual values for each waveform to determine a performance rating. Only 35 (56.5 percent) of the spirometers performed acceptably when measuring the 24 standard waveforms. Nine (14.5 percent) were marginal and 18 (29.0 percent) were unacceptable. Fifty-nine (95 percent) of the 62 spirometers were computerized. Software errors were found in 25 percent of the computerized systems evaluated. Although using a 3 L syringe for quality control purposes is essential, simple testing of spirometers with a 3 L calibrating syringe for validation purposes was inadequate to assess spirometer performance when compared to dynamic waveform testing. Dynamic waveform testing is essential to accurately measure and validate acceptability of spirometer system performance.

respiratory system,critical care medicine
Circadian Rhythm and Variability of Large and Small Airway Spirometric Variables in Healthy Individuals

Yingying Zhang,Yiting Wu,Xue Zhang,Chengjian Lv,Jingwang Lin,Lei Zhao,Yanmei Lin,Min Zhang,Wuping Bao

DOI: https://doi.org/10.1177/20552076241254698

2024-01-01

Digital Health

Abstract:Objective To assess the diurnal rhythm and variability of lung function in healthy individuals, encompassing both large and small airways. Methods A prospective study enrolled 35 healthy adults without a history of smoking. Initial spirometry and a bronchodilation test were performed using the Jaeger spirometer, followed by a seven-day continuous home monitoring using the GOSPT2000. We evaluated repeatability using the intraclass correlation coefficient and agreement through linear regression and Bland–Altman analyses. Circadian rhythm and variability in spirometric measurements were analyzed using the coefficient of variation (CV) and daily variation rate. Results The GOSPT2000 demonstrated strong repeatability and high agreement with the Jaeger spirometer. Notable findings included a decrease in nocturnal forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and FEV3 by 44, 59, and 53 mL, respectively. In contrast, peak expiratory flow at noon showed an increase of 0.143L/min. Small-airway variables, including forced expiratory flow at 50% and 75% of the FVC and maximum midexpiratory flow, showed no significant diurnal variation. The nocturnal CV for large-airway variables was ≤ 4%, while for small-airway variables, it was ≤ 11.89%. Conclusion This study has established a spectrum of variability for both large and small airways in healthy populations. The variability of small-airway variables is higher than that of large-airway variables. The investigation into the diurnal rhythms and variability characteristics of both large and small airway variables in the healthy population can serve as a foundation for diagnosing asthma or assessing the efficacy of asthma treatments.
Reference Values for Spirometry in Chinese Aged 4 to 80 Years

Wenhua Jian,Yi Gao,Chuangli Hao,Ning Wang,Tao Ai,Chuanhe Liu,Yongjian Xu,Jian Kang,Yang Lan,Huahao Shen,Wei-jie Guan,Nanshan Zhong,Jin-ping Zheng

DOI: https://doi.org/10.1016/j.chest.2016.02.500

IF: 9.6

2016-01-01

Chest

Abstract:BACKGROUND:Although there are over 1.34 billion Chinese in the world, nationwide spirometric reference values for Chinese are unavailable, which is usually based on Caucasian conversion. The aim of this study was to establish spirometric reference values for Chinese with a national wide sample.METHODS:We enrolled healthy non-smokers in 24 centers in Northeast, North, Northwest, Southwest, South, East and Central China from January 2007 to June 2010. Spirometry was performed according to American Thoracic Society and European Respiratory Society guidelines. Reference equations were established using the Lambda-Mu-Sigma (LMS) method for forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC, peak expiratory flow (PEF) and maximal midexpiratory flow (MMEF). Popular Caucasian reference values adjusted with ethnic conversion factors were validated with Chinese measured spirometry data. The present study also compared with other published Chinese equations for spirometry.RESULTS:A total of 7,115 eligible individuals aged 4 to 80 years (50.9% females) were recruited. Reference equations against age and height by gender were established, including predicted values and lower limits of normal (LLNs). Validated with Chinese data, the mean percentage differences of Caucasian reference values adjusted with ethnic conversion factors were -10.2% to 1.8%, and the percentages of total subjects under LLNs were 0.1% to 8.9%. Compared with this study, the percentage differences of previous Chinese studies ranged from -17.8% to 11.4%, which were found to significantly overestimate or underestimate lung function.CONCLUSIONS:This study established new reference values for better interpretation of spirometry in Chinese aged 4 to 80 years, while Caucasian references with adjustment were inappropriate for Chinese.
Evaluation of the Global Lung Function Initiative 2012 reference values for spirometry in China: a national cross-sectional study

Feilong Wang,Kun Wang,Cole Bowerman,Hogne Ulla,Jiaxing Sun,Marko Topalovic,Sanja Stanojevic,Qiang Li

DOI: https://doi.org/10.1183/13993003.00490-2022

IF: 24.3

2022-12-01

European Respiratory Journal

Abstract:China is facing a high burden of respiratory diseases. There are nearly 100 million people living with COPD and more than 45 million people living with asthma [1–3]. Pulmonary function tests are critical for early diagnosis and management of respiratory disease. An accurate interpretation of pulmonary function measurements requires reliable reference values. Due to complex interactions between genetics, socioeconomic status and other factors/exposures, population-specific reference equations are typically used to facilitate interpretation [4]. Currently, there are no nationally recognised spirometry reference values for the Chinese population. There have been several equations published but these have been limited due to small sample sizes, accounted for limited geographical areas, or lacked standardised quality control [5–8].

respiratory system
Restrictive Spirometric Pattern and Preserved Ratio Impaired Spirometry in a Population 50-64 Years

Kjell Torén,Anders Blomberg,Linus Schiöler,Andrei Malinovschi,Helena Backman,Kenneth Caidahl,Carl-Johan Carlhäll,Emil Ekbom,Magnus Ekström,Gunnar Engström,Jan Engvall,Maria J Eriksson,Viktor Hamrefors,Christer Janson,Åse Johnson,Mohammad Khalil,David Kylhammar,Anne Lindberg,Ulf Nilsson,Anna-Carin Olin,Ida Pesonen,Jessica Sjölund,C Magnus Sköld,Magnus Svartengren,Carl Johan Östgren,Per Wollmer

DOI: https://doi.org/10.1513/AnnalsATS.202403-242OC

2024-07-30

Abstract:Rationale: Knowledge regarding prevalence and shared and unique characteristics of Restrictive spirometric pattern (RSP) and Preserved ratio impaired spirometry (PRISm) is lacking for a general population investigated with post-bronchodilator spirometry and computed tomography of the lungs. Objectives: To investigate shared and unique features for RSP and PRISm. Methods: In the Swedish CArdioPulmonary bioImage Study (SCAPIS), a general population sample of 28,555 people aged 50 - 64 years (including 14,558 never-smokers) was assessed. The participants answered a questionnaire and underwent computed tomography of the lungs, post-bronchodilator spirometry, and coronary artery calcification score (CACS). Odds ratios (OR) with 95% confidence intervals (CI) were calculated using adjusted logistic regression. RSP was defined as FEV1/FVC≥0.70 and FVC<80%. PRISm was defined as FEV1/FVC≥0.70 and FEV1<80%. A local reference equation was applied. Measurements and results: The prevalence of RSP and PRISm were 5.1% (95% CI 4.9 - 5.4) and 5.1% (95% CI 4.8 - 5.3), respectively, with similar values seen in never-smokers. For RSP and PRISm, shared features were current smoking, dyspnea, chronic bronchitis, rheumatic disease, diabetes, ischemic heart disease (IHD), bronchial wall thickening, interstitial lung abnormalities (ILA), and bronchiectasis. Emphysema was uniquely linked to PRISm (OR 1.69, 1.36-2.10) vs 1.10 (0.84-1.43) for RSP. CACS≥300 was related to PRISm, but not among among never-smokers. Conclusions: PRISm and RSP have respiratory, cardiovascular, and metabolic conditions as shared features. Emphysema is only associated with PRISm. Coronary atherosclerosis may be associated with PRISm. Our results indicate that RSP and PRISm may share more features than not. This article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Technical standards for respiratory oscillometry

Gregory G King,Jason Bates,Kenneth I Berger,Peter Calverley,Pedro L de Melo,Raffaele L Dellacà,Ramon Farré,Graham L Hall,Iulia Ioan,Charles G Irvin,David W Kaczka,David A Kaminsky,Hajime Kurosawa,Enrico Lombardi,Geoffrey N Maksym,François Marchal,Beno W Oppenheimer,Shannon J Simpson,Cindy Thamrin,Maarten van den Berge,Ellie Oostveen

DOI: https://doi.org/10.1183/13993003.00753-2019

2020-02-27

Abstract:Oscillometry (also known as the forced oscillation technique) measures the mechanical properties of the respiratory system (upper and intrathoracic airways, lung tissue and chest wall) during quiet tidal breathing, by the application of an oscillating pressure signal (input or forcing signal), most commonly at the mouth. With increased clinical and research use, it is critical that all technical details of the hardware design, signal processing and analyses, and testing protocols are transparent and clearly reported to allow standardisation, comparison and replication of clinical and research studies. Because of this need, an update of the 2003 European Respiratory Society (ERS) technical standards document was produced by an ERS task force of experts who are active in clinical oscillometry research.The aim of the task force was to provide technical recommendations regarding oscillometry measurement including hardware, software, testing protocols and quality control.The main changes in this update, compared with the 2003 ERS task force document are 1) new quality control procedures which reflect use of "within-breath" analysis, and methods of handling artefacts; 2) recommendation to disclose signal processing, quality control, artefact handling and breathing protocols (e.g. number and duration of acquisitions) in reports and publications to allow comparability and replication between devices and laboratories; 3) a summary review of new data to support threshold values for bronchodilator and bronchial challenge tests; and 4) updated list of predicted impedance values in adults and children.
Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry

Graham L. Hall,Nicole Filipow,Gregg Ruppel,Tolu Okitika,Bruce Thompson,Jane Kirkby,Irene Steenbruggen,Brendan G. Cooper,Sanja Stanojevic

DOI: https://doi.org/10.1183/13993003.00289-2020

IF: 24.3

2021-03-01

European Respiratory Journal

Abstract:Background Measurement of lung volumes across the life course is critical to the diagnosis and management of lung disease. The aim of the study was to use the Global Lung Function Initiative methodology to develop all-age multi-ethnic reference equations for lung volume indices determined using body plethysmography and gas dilution techniques. Methods Static lung volume data from body plethysmography and gas dilution techniques from individual, healthy participants were collated. Reference equations were derived using the LMS (lambda-mu-sigma) method and the generalised additive models of location shape and scale programme in R. The impact of measurement technique, equipment type and being overweight or obese on the derived lung volume reference ranges was assessed. Results Data from 17 centres were submitted and reference equations were derived from 7190 observations from participants of European ancestry between the ages of 5 and 80 years. Data from non-European ancestry populations were insufficient to develop multi-ethnic equations. Measurements of functional residual capacity (FRC) collected using plethysmography and dilution techniques showed physiologically insignificant differences and were combined. Sex-specific reference equations including height and age were developed for total lung capacity (TLC), FRC, residual volume (RV), inspiratory capacity, vital capacity, expiratory reserve volume and RV/TLC. The derived equations were similar to previously published equations for FRC and TLC, with closer agreement during childhood and adolescence than in adulthood. Conclusions Global Lung Function Initiative reference equations for lung volumes provide a generalisable standard for reporting and interpretation of lung volumes measurements in individuals of European ancestry.

respiratory system
Pulmonary function in a cohort of heart-healthy individuals from Northern Sweden—a comparison with discordant reference values

DOI: https://doi.org/10.1186/s12890-023-02403-w

IF: 3.1

2023-04-06

BMC Pulmonary Medicine

Abstract:Dynamic spirometry is an important investigation to differentiate between impaired and normal lung function. This study aimed to evaluate the results of lung function testing in a cohort of subjects from Northern Sweden without any known heart or pulmonary disease. Our focus was to compare with two reference materials that have showed differences in the age-dependency of lung function in Swedish subjects.

respiratory system
Easy Interpretation in Three Steps

Josuel Ora,Federica Maria Giorgino,Federica Roberta Bettin,Mariachiara Gabriele,Paola Rogliani

DOI: https://doi.org/10.3390/jcm13133655

IF: 3.9

2024-06-23

Journal of Clinical Medicine

Abstract:Pulmonary function tests (PFTs) are pivotal in diagnosing and managing a broad spectrum of respiratory disorders. These tests provide critical insights into lung health, guiding diagnoses, assessing disease severity, and shaping patient management strategies. This review addresses the complexities and nuances inherent in interpreting PFT data, particularly in light of recent updates from the European Respiratory Society (ERS) and American Thoracic Society (ATS). These updates have refined interpretive strategies, moving away from definitive diagnostic uses of spirometry to a more probabilistic approach that better accounts for individual variability through the use of Z-scores and lower limits of normal (LLNs). Significantly, this narrative review delves into the philosophical shift in spirometry interpretation, highlighting the transition from direct clinical diagnostics to a more nuanced evaluation geared towards determining the likelihood of disease. It critiques the reliance on fixed ratios and emphasizes the need for reference values that consider demographic variables such as age, sex, height, and ethnicity, in line with the latest Global Lung Function Initiative (GLI) equations. Despite these advances, challenges remain in ensuring uniformity across different predictive models and reference equations, which can affect the accuracy and consistency of interpretations. This paper proposes a streamlined three-step framework for interpreting PFTs, aiming to unify and simplify the process to enhance clarity and reliability across various medical specialties. This approach not only aids in accurate patient assessments but also mitigates the potential for misdiagnosis and ensures more effective patient management. By synthesizing contemporary guidelines and integrating robust physiological principles, this review fosters a standardized yet flexible approach to PFT interpretation that is both scientifically sound and practically feasible.

medicine, general & internal
Transfer factor, lung volumes, resistance and ventilation distribution in healthy adults

Sylvia Verbanck,Alain Van Muylem,Daniel Schuermans,Ivan Bautmans,Bruce Thompson,Walter Vincken

DOI: https://doi.org/10.1183/13993003.00695-2015

IF: 24.3

2015-11-19

European Respiratory Journal

Abstract:Monitoring of chronic lung disease requires reference values of lung function indices, including putative markers of small airway function, spanning a wide age range. We measured spirometry, transfer factor of the lung for carbon monoxide ( T LCO ), static lung volume, resistance and ventilation distribution in a healthy population, studying at least 20 subjects per sex and per decade between the ages of 20 and 80 years. With respect to the Global Lung Function Initiative reference data, our subjects had average z-scores for forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC) and FEV 1 /FVC of −0.12, 0.04 and −0.32, respectively. Reference equations were obtained which could account for a potential dependence of index variability on age and height. This was done for (but not limited to) indices that are pertinent to asthma and chronic obstructive pulmonary disease studies: forced expired volume in 6 s, forced expiratory flow, T LCO , specific airway conductance, residual volume (RV)/total lung capacity (TLC), and ventilation heterogeneity in acinar and conductive lung zones. Deterioration in acinar ventilation heterogeneity and lung clearance index with age were more marked beyond 60 years, and conductive ventilation heterogeneity showed the greatest increase in variability with age. The most clinically relevant deviation from published reference values concerned RV/TLC values, which were considerably smaller than American Thoracic Society/European Respiratory Society-endorsed reference values.

respiratory system
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease

Anne E. Holland,Martijn A. Spruit,Thierry Troosters,Milo A. Puhan,Véronique Pepin,Didier Saey,Meredith C. McCormack,Brian W. Carlin,Frank C. Sciurba,Fabio Pitta,Jack Wanger,Neil MacIntyre,David A. Kaminsky,Bruce H. Culver,Susan M. Revill,Nidia A. Hernandes,Vasileios Andrianopoulos,Carlos Augusto Camillo,Katy E. Mitchell,Annemarie L. Lee,Catherine J. Hill,Sally J. Singh

DOI: https://doi.org/10.1183/09031936.00150314

IF: 24.3

2014-10-30

European Respiratory Journal

Abstract:Field walking tests are commonly employed to evaluate exercise capacity, assess prognosis and evaluate treatment response in chronic respiratory diseases. In recent years, there has been a wealth of new literature pertinent to the conduct of the 6-min walk test (6MWT), and a growing evidence base describing the incremental and endurance shuttle walk tests (ISWT and ESWT, respectively). The aim of this document is to describe the standard operating procedures for the 6MWT, ISWT and ESWT, which can be consistently employed by clinicians and researchers. The Technical Standard was developed by a multidisciplinary and international group of clinicians and researchers with expertise in the application of field walking tests. The procedures are underpinned by a concurrent systematic review of literature relevant to measurement properties and test conduct in adults with chronic respiratory disease. Current data confirm that the 6MWT, ISWT and ESWT are valid, reliable and responsive to change with some interventions. However, results are sensitive to small changes in methodology. It is important that two tests are conducted for the 6MWT and ISWT. This Technical Standard for field walking tests reflects current evidence regarding procedures that should be used to achieve robust results.

respiratory system
[Consensus of Chinese experts on product principles, quality control and clinical application of portable spirometer]

Pulmonary Function Assembly, Chinese Thoracic Society of Chinese Medical Association

DOI: https://doi.org/10.3760/cma.j.cn112147-20220302-00167

2022-10-12

Abstract:Compared with the traditional laboratory spirometer, the portable spirometer has obvious advantages, e.g., small size, portability, simple operation and low cost. The portable spirometer is a supplementary instrument in the primary health institutions when the laboratory spirometer is unavailable or inapplicable. However, there is still a lack of guidance in documents regarding the application of portable spirometer in China. This consensus elaborated the specific details of portable spirometer, such as the equipment hardware, the equipment quality requirement, the operation protocols, the quality control, the clinical application and the personnel training. The portable spirometer consists of a spirometer and a computer system. Its core component is the flow sensor, which retains the core functions of the traditional spirometer, i.e., regular pulmonary function and bronchodilation test, but does not have the ability to measure the total lung volume, residual volume and diffusion capacity. In addition, the portable spirometer needs to pass the quality inspection of the national and international authorities and needs to meet the standard of ISO26782 of 2009. The quality control for a portable spirometer includes equipment quality control, process quality control and report quality control, and its technical details are consistent with the quality control requirements of the laboratory spirometer. It can be widely used for screening of respiratory diseases, epidemiological investigation and regular physical check-up, clinical trials, management of chronic respiratory diseases, and examination on the disability. The training courses for the portable spirometer contain theory and practice curriculums, mostly for primary and community healthcare workers with various and flexible options. Furthermore, the portable spirometer has integrated many high-tech technologies that surpass the similar functions in the laboratory spirometer such as intelligent data transmission, cloud database, big data management, biosensors, etc. With the development of the high-tech, portable spirometer has become more and more intelligent and diversified, and is able to greatly improve the management model for chronic respiratory diseases in the future.
An Interrater Reliability Study of Pulmonary Function Assessment With a Portable Spirometer.

Hao Zhang,Li Li,Daozhen Jiao,Yanjie Yang,Chunhong Pan,Ling Ye,Sulan Wei,Meiling Jin

DOI: https://doi.org/10.4187/respcare.07116

2020-01-01

Respiratory Care

Abstract:BACKGROUND: In this study, we aimed to validate the agreement between pulmonary function measurements obtained with a portable spirometer and measurements obtained with conventional spirometry in Chinese pediatric and adult populations. METHODS: Pulmonary function testing was performed to evaluate subjects enrolled at Shanghai Zhongshan Hospital (n = 104) and Shanghai Children's Medical Center (n = 103). The portable spirometers and conventional devices were applied to each subject with a 20-min quiescent period between each measurement. Pulmonary function parameters of FVC, FEV1, peak expiratory flow, maximum expiratory flow at 25%, 50%, and 75% of FVC (MEF25, MEF50, and MEF75, respectively), and FEV1/FVC% were compared with intraclass correlation and Bland-Altman methods. RESULTS: A satisfactory concordance of pulmonary function was observed between spirometry measurements obtained with portable versus conventional spirometers. Intraclass correlation indicated excellent reliability (>0.75) for all pulmonary function indicators in pediatric and adult subjects. Significant positive correlations of all variables measured with different spirometers were observed (all P < .001). No significant bias was observed in either group, although limits of agreement varied. Funnel effects were observed for peak expiratory flow in pediatric subjects and for FVC, FEV1, MEF50, and MEF25 in adult subjects. CONCLUSIONS: The portable spirometer is an alternative to the conventional device for the measurement of pulmonary function. Compared with the conventional device, the portable spirometer is expected to provide convenient, operational, and financial advantages.
Guida pratica alla spirometria attraverso i casi

Chiara Udina,Sarah Contorno,Giulia Gortani,Massimo Maschio,Egidio Barbi

DOI: https://doi.org/10.53126/meb40450

2021-09-25

Medico e Bambino

Abstract:Spirometry is a very useful test in paediatric clinical practice. Nevertheless, to avoid making mistakes, it is important to keep in mind its role and what can be measured and how. “On which patients should spirometry be performed? What does the clinician want to rule out? Is the result reliable? What should be avoided?”. So, by answering these questions, it is possible to get the best out of this resource and interpret the results critically. For this purpose, this article is addressed to ‘non-experts’, it discusses the main points and provides practical ‘tricks’ through most common clinical cases.
Comparison of a portable, pneumotach flow-sensor–based spirometer (SpirofyTM) with the vitalograph alpha TouchTM spirometer in evaluating lung function in healthy individuals, asthmatics, and COPD patients—a randomized, crossover study

Deepak Talwar,S Balamurugan,Mahavir Modi,Sundeep Salvi,Meena Lopez,Rushika Shah,Abhijit Vaidya,Monica Barne,Sapna Madas,Nandan Kulkarni,Sandesh Sawant,Jaideep Gogtay

DOI: https://doi.org/10.1186/s12890-024-02972-4

IF: 3.1

2024-05-12

BMC Pulmonary Medicine

Abstract:SpirofyTM is India's first portable, pneumotach flow-sensor-based digital spirometer developed to diagnose asthma and chronic obstructive pulmonary disease (COPD). In this study, we compared the performance of the SpirofyTM device with that of the Vitalograph Alpha TouchTM spirometer in measuring the lung capacities of healthy individuals, asthmatics, and COPD patients. We also assessed the inter-device variability between two SpirofyTM devices.

respiratory system

Standardisation of spirometry

Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement

ERS/ATS technical standard on interpretive strategies for routine lung function tests

Clinlcal study of Medikro SplroStar USB portable splrometry application

Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations

Standard spirometry to assess emphysema in patients with chronic obstructive pulmonary disease: the Emphysema Severity Index (ESI)

Performance Evaluation of Contemporary Spirometers

Circadian Rhythm and Variability of Large and Small Airway Spirometric Variables in Healthy Individuals

Reference Values for Spirometry in Chinese Aged 4 to 80 Years

Evaluation of the Global Lung Function Initiative 2012 reference values for spirometry in China: a national cross-sectional study

Restrictive Spirometric Pattern and Preserved Ratio Impaired Spirometry in a Population 50-64 Years

Technical standards for respiratory oscillometry

Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry

Pulmonary function in a cohort of heart-healthy individuals from Northern Sweden—a comparison with discordant reference values

Easy Interpretation in Three Steps

Transfer factor, lung volumes, resistance and ventilation distribution in healthy adults

An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease

[Consensus of Chinese experts on product principles, quality control and clinical application of portable spirometer]

An Interrater Reliability Study of Pulmonary Function Assessment With a Portable Spirometer.

Guida pratica alla spirometria attraverso i casi

Comparison of a portable, pneumotach flow-sensor–based spirometer (SpirofyTM) with the vitalograph alpha TouchTM spirometer in evaluating lung function in healthy individuals, asthmatics, and COPD patients—a randomized, crossover study